GB2121289A - Intrauterine contraceptive device and method of its production - Google Patents
Intrauterine contraceptive device and method of its production Download PDFInfo
- Publication number
- GB2121289A GB2121289A GB08311183A GB8311183A GB2121289A GB 2121289 A GB2121289 A GB 2121289A GB 08311183 A GB08311183 A GB 08311183A GB 8311183 A GB8311183 A GB 8311183A GB 2121289 A GB2121289 A GB 2121289A
- Authority
- GB
- United Kingdom
- Prior art keywords
- metal
- iucd
- synthetic polymer
- weight
- intrauterine contraceptive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/142—Wirelike structures, e.g. loops, rings, spirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
Landscapes
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Intrauterine contraceptive devices made of synthetic polymer combined with metal include 1 to 30% wt. of at least one metal ingredient in a powdered state selected from copper, silver, gold and zinc. The powdered metal is distributed throughout the polymer material homogenously, and has a particle size of from 2 to 50 mu m.
Description
SPECIFICATION
Intrauterine contraceptive device and method
of its production
The invention relates to intrauterine
contraceptive devices made of synthetic polymer
combined with metal, the synthetic polymer
containing a metal ingredient.
At the present time there are approximately 80
million women all over the world using
intrauterine contraceptive devices, including about
400,000 women in Czechoslovakia. The
significance of family planning in the life of modern man is rising. The concept of "family
planning" has both quantitative and qualitative
aspects, namely to ensure the birth of physically
and psychologically sound children and to help
individuals with reduced fertility or infertility to
obtain desired fertility. Contraception seems to be
the most convenient method for family planning.
Contraception comprises means that enable the
sexual intercourse of two fertile heterosexual
individuals without the conception of a new
individual, these methods being reversible. Neither
abortion (being a repressive method), nor
sterilization, nor sexual abstinence are included.
High demands are made on contraception. The
method is required to be reliable, safe, and
innocuous to health, and at the same time
aesthetically acceptable and comparatively cheap.
No means meeting all these demands has yet
been developed in the world. In the early 1 960's
the first generation of intrauterine contraceptive
devices (IUCD) made of synthetic polymer without
metal were developed. They suffered from a
relatively large number of failures and secondary
unfavourable effects comprising spontaneous
IUCD expulsion from the uterine cavity, bleeding
and/or pain in consequence of which it was
necessary to remove the IUCD from the uterus.
These disadvantages and experience led to the
development of intrauterine contraceptive devices
of the second generation that keeps both
accordion effect (returns to its original shape) and
the principle of uterine fundus search (returns to
its original position). It is important that the shape
and the size of intrauterine contraceptive devices
approach the size and the shape of the uterine
cavity into which the IUCD shall be inserted as
optimally as possible. The intrauterine 'contraceptive device should be made of such
material and be of such shape so as to have
sufficient resilience to adjust to changes in the shape of the uterine cavity during the menstruous
cycle and during uterine contractions.It should
have sufficient plastic shape memory to return to
its original shape and original position after the
removal of these influences when the IUCD is to
occupy the uterine fundus with its largest part. In
spite of improved results the intrauterine
contraceptive devices of the second generation
were not of 100% reliability and without
secondary effects such as expulsion, bleeding, and
pain. This was the reason for the development of
intrauterine contraceptive devices of the third generation. "Medicate IUCD" was made by adding an effective substance. A metal is used as the effective substance most often, the metal being copper in the form of wire or a thin tube slid on or would round a part of intrauterine contraceptive device or in its surface layer.The disadvantage of metal used in the form of wire or a tube lies in metal corrosion in the intrauterine medium with subsequent wire or tube breakage, which increases the injury hazard. Higher consdmption of labour during IUCD production is not negligible either.
Synthetic steroids released from the intrauterine contraceptive device from a reservoir into the intrauterine medium are often used too.
The service life of intrauterine contraceptive devices with a reservoir of synthetic steroid hormones is restricted - as far as the release of this substance is concerned - because the reservoir empties within one or two years. Then it is necessary to withdraw the IUCD and substitute a new one. Another disadvantage of the intrauterine contraceptive device is that to reveal it (e.g. by X-rays) in the uterine cavity it is necessary to add a contrastive substance (for example barium sulphate) up to 25% by weight to the IUCD material, which reduces the possibility of increasing the metal content in the IUCD material.
The drawbacks mentioned above do not concern intrauterine contraceptive devices made of a synthetic polymer combined with metal according to the following invention.
The IUCD material includes at least one metal ingredient in a powdered state from 1 to 30% by weight selected from group Ib of the 4th, 5th or 6th periods or from group llb of the 4th period of the periodic table. The powdered metal is distributed throughout the material homogeneously, the size of the particles being from 2 to 50 Mm.
The material of the IUCD may contain copper in a quantity up to 25% by weight with silver added in a quantity up to 5% by weight.
The material of the IUCD may contain zinc in a quantity up to 25% by weight with silver added in a quantity up to 5% by weight.
A method of producing an intrauterine contraceptive device in accordance with the present invention is as follows:~
Synthetic polymer and powdered metal ingredient are homogenized in a mixing device and then remelted in a homogenizing extruder. The extrudate is granulated, then the granulated synthetic polymer with metal content is converted to a thermoplastic state in the fusion chamber of an injection press and then injected into the mould from which it is taken out as a finished intrauterine contraceptive device.
The advantage of an IUCD made of synthetic polymer with a metal content in accordance with the present invention lies in excluding undesirable effects with almost 100% effectiveness because the synthetic polymer is directly filled with a powdered metal up to 30% by weight. The powdered metal is released in a regulated quantity owing to the complex function of the uterus. Thus the long-term effectiveness of the intrauterine contraceptive device is ensured without injury hazard because metal is distributed throughout the IUCD material. Substitution of a contrastive substance (for example barium sulphate) for metal enables the detection of the IUCD placed in the uterine cavity by means other than X-ray methods.
Higher content of metal results in a greater likelihood of the IUCD retaining its resilience, which is important for its complex function.
Reduced consumption of labour during its production seems to be another advantage.
Reducing the number of abortions and health damage after abortion and saving bed capacity by securing as many women as possible for suitable contraception, is not negligible either. If one third of undesirable conceptions of 1,500 women resulting in abortions is avoided, 1,000- 1,500 bed/days are saved. This capacity can then be devoted to care for risk pregnancies or to the intensification of care for women suffering from gynaecological diseases.
Non-limiting examples of methods of IUCD production according to the present invention are as follows:
An IUCD made of a synthetic polymer combined with metal is formed by a synthetic polymer which contains a powdered metal ingredient from 1 to 30% by weight, the powdered metal being either copper, or zinc, or silver, or gold, and/or a mixture thereof (the preferred mixture being of copper and silver, or zinc and silver). The maximum metal weight ratio depends on the excreted metal volume limited by the quiescent physiological value of metal excreted in the urine (for copper 0.75 + 0.25 ,rmol/24 hours, for zinc 2.76 + 0.38 Mmol/24 hours, for silver 5.88 + 0.56 ,umol/24 hours).
The contaceptive effect of the IUCD according to this invention is complex and caused by the stimulation of the natural defensive capabilities of the human body. The IUCD inserted into the uterine cavity causes the emergence of an enormous number of macrophages that attack the foreign body placed in the intrauterine cavity. Thus the immune response of the body is evoked because excited macrophages attack both the
IUCD placed in the uterine cavity and spermatozoa moving into the intrauterine cavity. On the immunity side, spermatozoa are foreign to the woman's body, therefore they are phagocytosed by macrophages. Thus the number of spermatozoa is radically reduced and conception becomes impossible. Normally fertile semen (normospermia) becomes less fertile (oligospermia) and then infertile (azoospermia).
These facts are important in understanding the contraceptive effect for what is meant is a real contraceptive effect and not an antiembeddive or abortive effect. The contraceptive effect of the
IUCD is increased by adding a metal because a higher number of macrophages are excited so that smaller lUCD's can be used. Thus unfavourable bleeding effects and/or pain are reduced.
Experiments carried out by means of a scanning electron microscope have proved the macrophage phagocytizing effect. By adding one or more powdered metals to the polymer material it is possible to achieve the uniform distribution of metal and its release throughout the uterine cavity. In this it differs from an IUCD with wire or a thin tube wound round it, when release is not ensured from the whole surface of the intrauterine contraceptive device.
The following processes take place during the long-term insertion of the IUCD with metal within the uterine cavity:
(a) metal gets to the surface of a polymer material,
(b) metal diffuses from the interior of the device to its surface,
(c) the speed of metal release from the polymer material is influenced by the swelling of the IUCD, by the increase of porosity, and thus by the speed of diffusion processes of metal to the surface and from the surface into the surrounding medium,
(d) silver present in the material of the IUCD operates bactericidally.
A A method of producing an IUCD made of synethetic polymer combined with metal can be practised as follows.
A weighed volume of basic synthetic polymer and required ingredient are homogenized in a suitable mixing device, then remelted in an extruder with high homogenizing effectiveness.
The polymer extrudate is granulated by means of a granulating cutting machine, then the granulated synthetic polymer with metal content is converted into a thermoplastic state in the fusion chamber of an injection press. Then it is injected into a mould from which it is taken out as a finished intrauterine contraceptive device. The advantages of this method lie in the possibility of exact addition of powdered metals to powdered synthetic polymer (the preferred being copolymeric ethyl vinyl acetate) and its homogenization by means of a double-screw extruder.
An IUCD in accordance with the present invention can be used in veterinary practice too.
Claims (6)
1. An IUCD made of a synthetic polymer combined with metal containing at least one metal ingredient in a powdered state from 1 to 30% by weight selected from group lb of the 4th, 5th, or 6th periods or from group llb of the 4th period of the periodic table, the powdered metal being distributed throughout the material of the
IUCD homogenously and having a particle size of from 2 to 50 ,um.
2. An IUCD according to Claim 1 containing copper in a quantity up to 25% by weight with silver added to it in a quantity up to 5% by weight.
3. An IUCD according to Claim 1 containing zinc in a quantity up to 25% by weight with silver added to it in a quantity up to 5% by weight.
4. A method of producing an intrauterine contraceptive device in which a synthetic polymer and powdered metal ingredient are homogenized in a mixing device, remelted in a homogenizing extruder, extruded, granulated, and the granulated synthetic polymer with metal content converted into a thermoplastic state in the fusion chamber of an injection press and injected into a mould from which it is taken out as a finished intrauterine contraceptive device.
5. An IUCD made of a synthetic polymer combined with metal substantially as hereinbefore described with reference to the Examples of the invention.
6. A method of producing an intrauterine contraceptive device substantially as hereinbefore described with reference to the Examples of the invention.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS823204A CS232807B1 (en) | 1982-05-04 | 1982-05-04 | Inter-uterus anticonception little body and method of its making |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8311183D0 GB8311183D0 (en) | 1983-06-02 |
GB2121289A true GB2121289A (en) | 1983-12-21 |
GB2121289B GB2121289B (en) | 1985-03-27 |
Family
ID=5371451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08311183A Expired GB2121289B (en) | 1982-05-04 | 1983-04-25 | Intrauterine contraceptive device and method of its production |
Country Status (8)
Country | Link |
---|---|
BE (1) | BE896527A (en) |
CS (1) | CS232807B1 (en) |
DE (1) | DE3312766A1 (en) |
FI (1) | FI831281A0 (en) |
FR (1) | FR2526307A1 (en) |
GB (1) | GB2121289B (en) |
IT (1) | IT1164209B (en) |
NL (1) | NL8301372A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1307956C (en) * | 2005-11-26 | 2007-04-04 | 商丘雅康药械有限公司 | Nano silver intrauterine device |
FR2946526A1 (en) * | 2009-06-16 | 2010-12-17 | Cl Investissements | IUD |
NO339210B1 (en) * | 2005-04-05 | 2016-11-14 | Bayer Oy | An ultrasound-detectable intrauterine system and a method for improving ultrasound detection |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101934100B (en) * | 2010-08-03 | 2013-05-22 | 华中科技大学 | Composite material copper-containing intrauterine device with porous structure |
CN101934099B (en) * | 2010-08-03 | 2013-03-27 | 华中科技大学 | Porous-structure composite material for IUD (Intrauterine Device) and producing method thereof |
CN112999433B (en) * | 2021-02-23 | 2022-07-05 | 吴江永元生物科技有限公司 | Cu-Zn composite material intrauterine device and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1318175A (en) * | 1970-08-28 | 1973-05-23 | Robinson R R | Intrauterine device |
GB1334613A (en) * | 1970-11-30 | 1973-10-24 | Anderson I H W | Contraceptive devices |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3834378A (en) * | 1970-11-12 | 1974-09-10 | Robins Co Inc A H | Intrauterine device |
FR2202438A5 (en) * | 1972-10-09 | 1974-05-03 | Robins Co Inc A H | Intrauterine contraceptive - of ethylene-vinyl copolymer |
EG11114A (en) * | 1973-12-06 | 1977-01-31 | Schering Ag | Dispositif contraceptif intra-uterin |
FR2433949A1 (en) * | 1978-08-25 | 1980-03-21 | Commissariat Energie Atomique | HYDROPHOBIC SUBSTRATE CAPABLE OF RELEASING A CHEMICAL SUBSTANCE |
-
1982
- 1982-05-04 CS CS823204A patent/CS232807B1/en unknown
-
1983
- 1983-04-09 DE DE19833312766 patent/DE3312766A1/en not_active Ceased
- 1983-04-15 FI FI831281A patent/FI831281A0/en not_active Application Discontinuation
- 1983-04-19 NL NL8301372A patent/NL8301372A/en not_active Application Discontinuation
- 1983-04-21 BE BE0/210602A patent/BE896527A/en not_active IP Right Cessation
- 1983-04-25 GB GB08311183A patent/GB2121289B/en not_active Expired
- 1983-04-29 FR FR8307121A patent/FR2526307A1/en active Pending
- 1983-05-02 IT IT20888/83A patent/IT1164209B/en active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1318175A (en) * | 1970-08-28 | 1973-05-23 | Robinson R R | Intrauterine device |
GB1334613A (en) * | 1970-11-30 | 1973-10-24 | Anderson I H W | Contraceptive devices |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO339210B1 (en) * | 2005-04-05 | 2016-11-14 | Bayer Oy | An ultrasound-detectable intrauterine system and a method for improving ultrasound detection |
CN1307956C (en) * | 2005-11-26 | 2007-04-04 | 商丘雅康药械有限公司 | Nano silver intrauterine device |
FR2946526A1 (en) * | 2009-06-16 | 2010-12-17 | Cl Investissements | IUD |
WO2010146295A1 (en) * | 2009-06-16 | 2010-12-23 | Cl Investissements | Intrauterine device |
Also Published As
Publication number | Publication date |
---|---|
FI831281A0 (en) | 1983-04-15 |
NL8301372A (en) | 1983-12-01 |
IT1164209B (en) | 1987-04-08 |
IT8320888A1 (en) | 1984-11-02 |
BE896527A (en) | 1983-08-16 |
GB2121289B (en) | 1985-03-27 |
DE3312766A1 (en) | 1983-11-10 |
FR2526307A1 (en) | 1983-11-10 |
CS232807B1 (en) | 1985-02-14 |
IT8320888A0 (en) | 1983-05-02 |
GB8311183D0 (en) | 1983-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3803308A (en) | Method of contraception with a soluble non-toxic copper or zinc compound | |
US3563235A (en) | Intrauterine contraceptive method | |
CN102355872B (en) | Novel intra uterine device | |
Roche | Synchronization of oestrus in heifers with implants of progesterone | |
US4264575A (en) | Contraceptive methods and compositions | |
PL100167B1 (en) | MEDICINAL MECHANICAL CONTRACEPTIVE AGENT | |
JP2010509964A (en) | Helical drug delivery system | |
US4040417A (en) | Intrauterine device | |
Segal et al. | Contraceptive Technology Current and Prospective Methods | |
GB2121289A (en) | Intrauterine contraceptive device and method of its production | |
Sam | Controlled release contraceptive devices: a status report | |
US3895103A (en) | Intrauterine contraceptive device containing certain pharmaceutically acceptable steroids | |
Zipper et al. | Four years experience with the Cu7 200 device-endouterine copper in fertility control | |
US4264576A (en) | Contraceptive methods and compositions | |
Zaneveld et al. | Primate model for the evaluation of vaginal contraceptives | |
US4565694A (en) | Contraceptive vaginal tablets | |
Orlans | Copper IUDs: a review of the literature | |
Medel et al. | Preliminary observations on the effects of copper, zinc and polyethylene IUF Bs. on the uterine motility of the rabbit | |
Taverne et al. | Preliminary observations on myometrial electrical activity before, during and after parturition in the cow | |
Borko et al. | A comparative clinical trial of the contraceptive sponge and Neo Sampoon tablets | |
US5238928A (en) | Methods and materials for obtaining phenotypic females despite androgen administration | |
US4264578A (en) | Contraceptive methods and compositions | |
CN210728404U (en) | Fixed type levonorgestrel intrauterine sustained-release device | |
USRE28399E (en) | Intrauterine contraceptive method | |
Bruce et al. | The effects of medroxyprogesterone acetate on the maintenance of pregnancy in ovariectomized rats and rabbits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |